These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 31216743

  • 1. Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding.
    Shah NR, Bulitta JB, Kinzig M, Landersdorfer CB, Jiao Y, Sutaria DS, Tao X, Höhl R, Holzgrabe U, Kees F, Stephan U, Sörgel F.
    Pharmaceutics; 2019 Jun 18; 11(6):. PubMed ID: 31216743
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteers.
    Jiao Y, Kim TH, Tao X, Kinzig M, Landersdorfer CB, Drescher SK, Sutaria DS, Moya B, Holzgrabe U, Sörgel F, Bulitta JB.
    Eur J Pharm Sci; 2018 Oct 15; 123():416-428. PubMed ID: 30076955
    [Abstract] [Full Text] [Related]

  • 4. Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers.
    Bulitta JB, Kinzig M, Landersdorfer CB, Holzgrabe U, Stephan U, Sörgel F.
    Antimicrob Agents Chemother; 2011 Jun 15; 55(6):2927-36. PubMed ID: 21402834
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.
    Sörgel F, Stephan U, Wiesemann HG, Gottschalk B, Stehr C, Rey M, Böwing HB, Dominick HC, Geldmacher von Mallinckrodt M.
    Infection; 1987 Jun 15; 15(5):385-96. PubMed ID: 3319914
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis.
    Park AYJ, Wang J, Jayne J, Fukushima L, Rao AP, D'Argenio DZ, Beringer PM.
    Antimicrob Agents Chemother; 2018 Sep 15; 62(9):. PubMed ID: 29914949
    [Abstract] [Full Text] [Related]

  • 10. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME, Kornhauser DM.
    Arch Pediatr Adolesc Med; 1994 Mar 15; 148(3):266-71. PubMed ID: 8130858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of three techniques for body composition analysis in cystic fibrosis.
    Lands LC, Gordon C, Bar-Or O, Blimkie CJ, Hanning RM, Jones NL, Moss LA, Webber CE, Wilson WM, Heigenhauser GJ.
    J Appl Physiol (1985); 1993 Jul 15; 75(1):162-6. PubMed ID: 8376263
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulation.
    Vinks AA, van Rossem RN, Mathôt RA, Heijerman HG, Mouton JW.
    Antimicrob Agents Chemother; 2007 Sep 15; 51(9):3049-55. PubMed ID: 17576827
    [Abstract] [Full Text] [Related]

  • 14. Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy.
    Matar R, Le Bourgeois M, Scheinmann P, de Blic J, Ponvert C.
    Pediatr Allergy Immunol; 2014 Feb 15; 25(1):88-93. PubMed ID: 24237053
    [Abstract] [Full Text] [Related]

  • 15. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM, Szefler SJ, Hill MR, Jusko WJ, Larsen GL, Accurso FJ.
    J Pediatr; 1992 May 15; 120(5):789-94. PubMed ID: 1578318
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of meropenem in patients with cystic fibrosis.
    Christensson BA, Ljungberg B, Eriksson L, Nilsson-Ehle I.
    Eur J Clin Microbiol Infect Dis; 1998 Dec 15; 17(12):873-6. PubMed ID: 10052554
    [Abstract] [Full Text] [Related]

  • 18. Population Pharmacokinetic Analyses for Ertapenem in Subjects with a Wide Range of Body Sizes.
    Lakota EA, Landersdorfer CB, Zhang L, Nafziger AN, Bertino JS, Bhavnani SM, Forrest A.
    Antimicrob Agents Chemother; 2018 Oct 15; 62(10):. PubMed ID: 30061283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.